RESINNOVA CLINICAL DIAGNOSTICS, LLC
NPI 1699421966
Clinical Medical Laboratory in Frederick, MD

Active since February 25, 2022CLIA 21D2229517 · Accreditation
321 BALLENGER CENTER DR STE 235, FREDERICK, MD 21703(240) 221-3830(240) 617-4473 Get Directions Write a Review

NPPES record last updated: May 8, 2025. Verified against the NPPES registry weekly; last sync: August 30, 2026.

Record update history: May 8, 2025, Aug 18, 2023, Feb 25, 2022 (3 updates tracked since 2022).

About Resinnova Clinical Diagnostics, Llc NPPES

Official registry information on file with the National Plan and Provider Enumeration System.

RESINNOVA CLINICAL DIAGNOSTICS, LLC (NPI 1699421966) is a healthcare organization registered as a clinical medical laboratory in Frederick, Maryland and active in the NPI registry since February 2022. The organization holds an CLIA Accreditation certificate valid through February 6, 2027 and lists Matthew Hardwick, Ceo, as its authorized official.

NPPES Registry Identity

NPI1699421966
Entity TypeOrganization
Primary Taxonomy291U00000X
Legal Business NameRESINNOVA CLINICAL DIAGNOSTICS, LLC
Location Address321 BALLENGER CENTER DR STE 235Frederick, MD 21703-4568
Mailing Address321 Ballenger Center Dr Ste 235Frederick, MD 21703-4568 · (240) 221-3830 · Fax (240) 617-4473
Fax(240) 617-4473
Organization SubpartNo
Authorized OfficialMatthew HardwickCeo · (240) 221-3830
Enumeration DateFebruary 25, 2022
Last NPPES UpdateMay 8, 20253 updates tracked since enumeration
NPPES CertifiedMay 8, 2025
NPI 1699421966 is a valid, active identifier and passes the ISO check-digit test.

Specialties & Licenses

Primary SpecialtyClinical Medical LaboratoryLaboratories
Taxonomy Code291U00000X
Definition
(1) A clinical laboratory is a facility for the biological, microbiological, serological, chemical, immunohematological, hematological, biophysical, cytological, pathological, or other examination of materials derived from the human body for the purpose of providing information for the diagnosis, prevention, or treatment of any disease or impairment of, human beings. These examinations also include procedures to determine, measure, or otherwise describe the presence or absence of various substances or organisms in the body. Facilities only collecting or preparing specimens (or both) or only serving as a mailing service and not performing testing are not considered clinical laboratories. (2) Any facility that examines materials from the human body for purposes of providing information for the diagnosis, prevention, or treatment of any disease or impairment of, or the assessment of, the health of human beings. Typical divisions of a clinical laboratory include hematology, cytology, bacteriology, histology, biochemistry, medical toxicology, and serology.
321 BALLENGER CENTER DR STE 235, Frederick, MD 21703

CLIA Laboratory Certificates CMS CLIA

Laboratory certificates issued under the Clinical Laboratory Improvement Amendments (CLIA) program, which sets federal quality standards for human laboratory testing in the United States. There is no official CMS crosswalk between CLIA and NPI numbers; these certificates are associated with this NPI by matching facility names, locations and phone numbers in the CMS CLIA registry.

Certificate of Accreditation 21D2229517

Resinnova Clinical Diagnostics LLC · Frederick, MD
Active · expires Feb 6, 2027
CLIA Number21D2229517
Laboratory TypeIndependent
Certificate Effective DateFebruary 7, 2025
Certificate Expiration DateFebruary 6, 2027
Laboratory DirectorDr. Sharon Master
Laboratory Phone(240) 485-8973
Laboratory LocationResinnova Clinical Diagnostics LLC321 Ballenger Center Dr Suite 235, Frederick, MD 21703
CLIA data matches this NPI record on: Address Name
This is a certificate that is issued to a laboratory on the basis of the laboratory's accreditation by an accreditation organization approved by CMS.

Areas of Expertise CMS Part B claims 6

Services this provider delivered to Medicare fee-for-service patients, from the CMS Medicare utilization data. Higher counts generally reflect more experience with a service; care delivered outside Medicare is not included.

Detection test by nucleic acid for organism, amplified probe technique 87798
A nucleic acid detection test is a procedure to identify specific organisms in your body. This test uses an amplified probe technique, which magnifies the genetic material of the organism, making it easier to detect. It's a precise way to diagnose infections.
1,209 services78 patients
Detection test for candida species (yeast), amplified probe technique 87481
This test helps identify Candida, a type of fungus often present in the human body. An amplified probe technique is used, which enhances detection of the fungus in a sample. This method increases the accuracy of the test, helping to determine the best treatment.
98 services78 patients
Detection test by nucleic acid for strep (streptococcus, group b), amplified probe technique 87653
A detection test by nucleic acid for Group B Strep uses an amplified probe technique. This test identifies the presence of Group B Strep bacteria in the body. It involves collecting a sample, usually a swab, which is then examined in a lab for the bacteria's genetic material.
93 services78 patients
Bacterial colony count, urine 87086
A bacterial colony count, urine, is a laboratory test that checks a urine sample for bacteria. It helps to identify if an infection is present in the urinary system. High numbers of bacteria in the urine can indicate a urinary tract infection (UTI).
67 services34 patients
Detection test by nucleic acid for vancomycin resistance strep (vre), amplified probe technique 87500
The detection test by nucleic acid for vancomycin-resistant strep (VRE) is a laboratory procedure. It uses an amplified probe technique to identify specific genetic material in bacteria. This helps determine if the bacteria are resistant to the antibiotic vancomycin.
44 services36 patients
Detection test by nucleic acid for staphylococcus aureus, methicillin resistant (mrsa bacteria), amplified probe technique 87641
A detection test by nucleic acid for MRSA bacteria uses an amplified probe technique. It's a lab procedure that identifies the presence of MRSA, a type of bacteria resistant to many antibiotics. This test helps in deciding the best treatment.
43 services35 patients

Frequently Asked Questions NPPES & CMS

Common questions about this NPI record, answered from the official NPPES registry and CMS datasets shown on this page.

What is Resinnova Clinical Diagnostics, LLC's NPI number?

The NPI number for Resinnova Clinical Diagnostics, LLC is 1699421966. It was assigned to this organization in the NPPES registry on February 25, 2022.

Where is Resinnova Clinical Diagnostics, LLC located?

Resinnova Clinical Diagnostics, LLC is located at 321 Ballenger Center Dr Ste 235, Frederick, MD 21703. The listed phone number is (240) 221-3830.

What is Resinnova Clinical Diagnostics, LLC's specialty?

The primary specialty registered for this NPI is Clinical Medical Laboratory with taxonomy code 291U00000X.

Does Resinnova Clinical Diagnostics, LLC hold a CLIA laboratory certificate?

Yes. A Certificate of Accreditation (number 21D2229517) is associated with this NPI, valid through February 6, 2027. CLIA certificates authorize laboratory testing under the federal Clinical Laboratory Improvement Amendments program.

When was this NPI record last updated?

The NPPES record for Resinnova Clinical Diagnostics, LLC was last updated on May 8, 2025. NPI Profile syncs weekly with the NPPES registry data releases published by CMS. This NPI record was last updated 15 months ago. If this record has changed at CMS more recently, you can request an on-demand re-check against the live CMS registry, directly from this page.